Evidence map›Paper›PMID 42839934›Full record

ArticleFrontiers in immunology2026

Case Report:

Jisan Sun, Zhiwei Xiong, Haizhou Hao, Wentao Jiang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jisan Sun *Department of Liver Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China.
Zhiwei Xiong *Department of Liver Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China.
Haizhou HaoDepartment of Liver Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China.
Wentao JiangDepartment of Liver Transplantation, First Central Hospital of Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Split liver transplantation (SLT) and controlled donation after circulatory death (cDCD) are two strategies used to expand the liver graft pool, but cDCD livers have traditionally been considered unsuitable for splitting because of warm ischemic injury, donor instability, and technical complexity. Normothermic regional perfusion (NRP) can restore oxygenated abdominal perfusion after death declaration and may create a physiologic window for Case presentation: We report two cDCD donation procedures in which NRP supported Conclusion: This case series supports the technical feasibility of NRP-assisted

Indexed as

Liver TransplantationPerfusionTissue DonorsHumansTissue and Organ ProcurementTreatment OutcomeWarm Ischemiacase seriescontrolled donation after circulatory deathnormothermic regional perfusionoutcomessplit liver transplantation

Identifiers

PMID42839934
PMCPMC13638372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.